Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN for Plasmacytoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where CISPLATIN was used for Plasmacytoma.

Most Reported Side Effects for CISPLATIN

Side Effect Reports % Deaths Hosp.
Off label use 4,359 9.2% 746 1,415
Disease progression 3,746 7.9% 880 500
Neutropenia 3,095 6.5% 464 920
Febrile neutropenia 3,010 6.3% 580 1,580
Nausea 2,923 6.2% 282 1,470
Drug ineffective 2,608 5.5% 744 607
Thrombocytopenia 2,565 5.4% 410 911
Anaemia 2,530 5.3% 338 1,111
Vomiting 2,326 4.9% 286 1,314
Diarrhoea 2,022 4.3% 376 1,069
Malignant neoplasm progression 2,004 4.2% 726 446
Pyrexia 1,863 3.9% 243 1,263
Myelosuppression 1,849 3.9% 106 843
Acute kidney injury 1,783 3.8% 279 1,162
Fatigue 1,394 2.9% 161 561

Other Indications for CISPLATIN

Diffuse large b-cell lymphoma (2,703) Product used for unknown indication (2,614) Non-small cell lung cancer (1,762) Plasma cell myeloma (1,239) Oesophageal carcinoma (1,094) Lung adenocarcinoma (1,003) Lung neoplasm malignant (988) Osteosarcoma (975) Chemotherapy (958) Cholangiocarcinoma (923)

Other Drugs Used for Plasmacytoma

LENALIDOMIDE (1,246) DEXAMETHASONE (245) BORTEZOMIB (191) POMALIDOMIDE (191) CYCLOPHOSPHAMIDE (95) DARATUMUMAB (79) CARFILZOMIB (66) THALIDOMIDE (60) IXAZOMIB (38) DOXORUBICIN (36)

Related Pages

CISPLATIN Full Profile All Plasmacytoma Drugs CISPLATIN Demographics CISPLATIN Timeline